Faster Entry Sought for Generics
Despite efforts to speed up approval of generic drugs, Americans still spend billions extra for prescriptions because of delays engineered by brand-name pharmaceutical companies. Pending legislation could help.
Faster Entry Sought for Generics
Despite efforts to speed up approval of generic drugs, Americans still spend billions extra for prescriptions because of delays engineered by brand-name pharmaceutical companies. Pending legislation could help.